Research on Improving Sleep During Pregnancy
RISE
Randomized Controlled Trial of Mindfulness-based Stress Reduction Plus Prenatal Sleep Supplement Versus Usual Care: Acceptability, Feasibility, and Adherence
2 other identifiers
interventional
52
1 country
1
Brief Summary
The overarching goal is to utilize a randomized control design to examine acceptability, feasibility, and adherence of mindfulness-based stress reduction plus prenatal sleep supplement (MBSR+PS) compared to treatment as usual among pregnant people with poor sleep quality (n=50).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2021
CompletedFirst Posted
Study publicly available on registry
August 24, 2021
CompletedStudy Start
First participant enrolled
September 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2022
CompletedResults Posted
Study results publicly available
November 18, 2023
CompletedNovember 18, 2023
November 1, 2023
10 months
August 17, 2021
June 6, 2023
November 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With a Total Score Greater Than or Equal to 24 on the 8-item Client Satisfaction Questionnaire (CSQ-8) at 12 Weeks
The Client Satisfaction Questionnaire (CSQ-8) score ranges from 8 to 32, with high scores indicating greater satisfaction. The CSQ-8 score of participants randomized to MBSR+PS will be reported; participants randomized to TAU will not complete the CSQ-8 as the questions pertain to the MBSR+PS program.
Post-intervention, an average of 12 weeks
Secondary Outcomes (18)
Number of Participants Who Attend at Least One Session of MBSR and the PS Supplement From Baseline to 12 Weeks
Baseline to post-intervention, an average of 12 weeks
Number of Participants Completing Endpoint Measures at 12 Weeks
Post-intervention, an average of 12 weeks
Completeness of Study Measures at Baseline and at 12 Weeks
Baseline and post-intervention, an average of 12 weeks
Percentage of MBSR and PS Sessions Attended
Baseline to post-intervention, an average of 12 weeks
Frequency of Home Practices From Baseline to 12 Weeks
Baseline to post-intervention, an average of 12 weeks
- +13 more secondary outcomes
Study Arms (2)
Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement (MBSR+PS)
EXPERIMENTALThe study intervention is standard mindfulness-based stress reduction (MBSR), which will be delivered through 8 weekly 2.5-hour sessions via video conferencing to groups of 20-30 pregnant and non-pregnant people. MBSR also consists of a 2.5-hour orientation session, a 30-minute private interview with the instructor, and an all-day retreat, all conducted via video conferencing. The supplemental prenatal sleep content will be delivered through 6-8 30-minute sessions via video conferencing either individually or to small groups, and draws material from mindfulness-based therapy for insomnia, mindfulness-based childbirth and parenting program, and cognitive behavior therapy for prenatal insomnia.
Treatment as Usual
OTHERThe control condition was designed to reflect standard care for insomnia patients. No limits are placed on receiving non-study treatment, including medication or psychotherapy, with the exception of asking participants to refrain from participating in non-study mindfulness practice. Use of non-study treatment will be tracked.
Interventions
MBSR+PS
TAU
Eligibility Criteria
You may qualify if:
- Pregnancy 12-28 weeks gestation at time of intervention start
- years of age or older
- Regular access to a web-enabled computer, phone or tablet
- Ability to read and speak English, and to provide informed consent
- Poor sleep quality (PSQI \> 5)
You may not qualify if:
- Self-reported sleep disorder (e.g. sleep apnea, narcolepsy, parasomnia, circadian rhythm disorder)
- Shift-work or nighttime caregiving responsibilities
- Psychological, medical, or other issues that necessitate priority treatment (e.g. active suicidality, probable depression (PHQ-9 ≥ 10), psychosis, on bed rest, multiple gestation)
- Current regular mindfulness practice (\>20 minutes/week)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94118, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Jennifer Felder
- Organization
- University of California, San Francisco
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer N Felder, PhD
University of California, San Francisco
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2021
First Posted
August 24, 2021
Study Start
September 8, 2021
Primary Completion
June 29, 2022
Study Completion
July 14, 2022
Last Updated
November 18, 2023
Results First Posted
November 18, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share